Myeloid Sarcoma in the Sinonasal Cavity with Orbital Involvement: A Case Report

Introduction: Myeloid sarcoma (MS) is a tumor mass that arises outside of the bone marrow area and is composed of either mature or not myeloid blasts of white blood cells. Acute myeloid leukemia (AML), chronic myeloid leukemia (CML) with an imminent blast crisis, and other underlying undiagnosed myeloproliferative disorders are frequently linked to MS, an uncommon disease. Without a history of leukemia, MS is difficult to diagnose and might be misdiagnosed for lymphoma or undifferentiated carcinoma. For patients, correct tissue diagnosis based on immunohistochemistry and histomorphology is important.Case Presentation: Here, we present a 27-year-old woman who had a surgical procedure in The Department of Otorhinolaryngology-Head and Neck Surgery with the chief complaint of right nasal congestion and growing right eye protrusion. A solid mass in the right sinonasal region with infiltration into the retrobulbar area was confirmed by a head computed tomography (CT) scan. Cells with small to medium-sized cells, finely distributed chromatin, tiny nucleoli, and sparse cytoplasm were examined under a microscope. These cells were grouped in diffuse, linear, or Indian file patterns. Microscopic examination revealed morphology of myeloid tumor. Immunohistochemistry analysis emphasized the diagnosis of myeloid sarcoma. The patient then had chemotherapy, comprising of six cycles of docetaxel and carboplatin. After completing chemotherapy, a reduction in the size of the tumor mass was observed.Conclusions: MS was diagnosed based on histological, radiographic, and immunohistochemical studies. Additional immunohistochemistry analysis testing is necessary to rule out a number of differential diagnoses when diagnosing MS in patients without a history of leukemia or hematological malignancy. The positive expression of myeloid markers such as CD68, CD15, CD33, and CD34 supports a diagnosis of MS.

Authors

Institutions

Publication Details

Journal
Indonesian Journal of Cancer
Published
2024-12-23
DOI
https://doi.org/10.33371/ijoc.v18i4.1185
Primary Topic
Multiple Myeloma Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Myeloid Sarcoma in the Sinonasal Cavity with Orbital Involvement: A Case Report

Dianli Fitriani, Eriza Eriza, Krisna Murti
Indonesian Journal of Cancer
Multiple Myeloma Research and Treatments
article

Myeloid Sarcoma in the Sinonasal Cavity with Orbital Involvement: A Case Report

Dianli Fitriani, Eriza Eriza, Krisna Murti
article en

Abstract

Introduction: Myeloid sarcoma (MS) is a tumor mass that arises outside of the bone marrow area and is composed of either mature or not myeloid blasts of white blood cells. Acute myeloid leukemia (AML), chronic myeloid leukemia (CML) with an imminent blast crisis, and other underlying undiagnosed myeloproliferative disorders are frequently linked to MS, an uncommon disease. Without a history of leukemia, MS is difficult to diagnose and might be misdiagnosed for lymphoma or undifferentiated carcinoma. For patients, correct tissue diagnosis based on immunohistochemistry and histomorphology is important.Case Presentation: Here, we present a 27-year-old woman who had a surgical procedure in The Department of Otorhinolaryngology-Head and Neck Surgery with the chief complaint of right nasal congestion and growing right eye protrusion. A solid mass in the right sinonasal region with infiltration into the retrobulbar area was confirmed by a head computed tomography (CT) scan. Cells with small to medium-sized cells, finely distributed chromatin, tiny nucleoli, and sparse cytoplasm were examined under a microscope. These cells were grouped in diffuse, linear, or Indian file patterns. Microscopic examination revealed morphology of myeloid tumor. Immunohistochemistry analysis emphasized the diagnosis of myeloid sarcoma. The patient then had chemotherapy, comprising of six cycles of docetaxel and carboplatin. After completing chemotherapy, a reduction in the size of the tumor mass was observed.Conclusions: MS was diagnosed based on histological, radiographic, and immunohistochemical studies. Additional immunohistochemistry analysis testing is necessary to rule out a number of differential diagnoses when diagnosing MS in patients without a history of leukemia or hematological malignancy. The positive expression of myeloid markers such as CD68, CD15, CD33, and CD34 supports a diagnosis of MS.

Indonesian Journal of CancerVol. 18(4)
Sriwijaya University (ID)
Good health and well-being
Openalex Percentile: Top 56%
Multiple Myeloma Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Myeloid Sarcoma in the Sinonasal Cavity with Orbital Involvement: A Case Report — Dianli Fitriani, Eriza Eriza, et al. · Indonesian Journal of Cancer (2024) | TGRS Research Map | TGRS